1-4 of 4
Peter T. Daniel, MD
Close
Sort by
Journal Articles

p38 MAPK Mediates Inhibition of Activation Induced Cell Death in T Lymphocytes Via Upregulation of Bcl-x L and FLIP short upon Ligation of CD137/4-1BB or CD28.

Christian Scholz, MD, Lilian Stärck, Mario Lehmann, Bernd Dörken, MD, Peter T. Daniel, MD
Journal: Blood
Blood (2005) 106 (11): 3320.
https://doi.org/10.1182/blood.V106.11.3320.3320
Published: 2005
Journal Articles

Arsenic Trioxide Induces Regulated, Death Receptor- and Caspase-Independent Cell Death through the Mitochondrial Death Pathway.

Christian Scholz, MD, Antje Richter, Mario Lehmann, Klaus Schulze-Osthoff, MD, Bernd Dörken, MD, Peter T. Daniel, MD
Journal: Blood
Blood (2005) 106 (11): 4421.
https://doi.org/10.1182/blood.V106.11.4421.4421
Published: 2005
Journal Articles

Sensitivity of Childhood Acute Lymphoblastic Leukemia (ALL) to Idarubicin Is Significantly Higher Than to Daunorubicin Treatment Based on Ex Vivo Apoptosis Induction.

Aram Prokop, MD, PhD, Banu Bagci, Guenaelle Lingfeld, MD, Lucia Badiali, Karin Garbrecht, Ulrike Mietzsch, MD, Thomas Wieder, PhD, Peter T. Daniel, MD, Günter Henze, MD
Journal: Blood
Blood (2004) 104 (11): 4495.
https://doi.org/10.1182/blood.V104.11.4495.4495
Published: 2004
Journal Articles

Iron Containing Nucleosides as New Cytostatic Substances for Cancer and Leukemia Therapy, Especially for Therapy of Relapsed ALL in Childhoodtransfusion of Red Blood Cells under Shock Conditions in the Rat Microvasculature.

Aram Prokop, MD, PhD, Thomas Wieder, PhD, Daniel Schlawe, PhD, Holger Lode, MD, Guenter Henze, MD, Peter T. Daniel, MD, Hans G. Schmalz, PhD
Journal: Blood
Blood (2004) 104 (11): 2085.
https://doi.org/10.1182/blood.V104.11.2085.2085
Published: 2004